Showing results (3121-3130 of 6,517) with videos related to

Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Low-intensity pulsed ultrasound activated the anti-tumor immunity by irradiating the spleen of mice in 4 T-1 breast cancerYi Xia, Meijie Yang, Xinfang Xiao, et al.
Cancer Immunology, Immunotherapy : CII|January 18, 2024
A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patientsYa-Xian Wu, Bo-Yu Tian, Xin-Yuan Ou, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
HDAC6 inhibitor ACY-1215 enhances STAT1 acetylation to block PD-L1 for colorectal cancer immunotherapyYuqing Wen, Shuyu Ye, Zhengshuo Li, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2024
Activation of cytotoxic lymphocytes through CD6 enhances killing of cancer cellsMikel Gurrea-Rubio, Qi Wu, M Asif Amin, et al.
Cancer Immunology, Immunotherapy : CII|March 30, 2024
Prenatal inflammation exposure accelerates lung cancer tumorigenesis in offspring mouse: possible links to IRE1α/XBP1-mediated M2-like polarization of TAMs and PD-L1 up-expressionJingbo Ma, Jian Tan, Weiqiang Zhang, et al.
Cancer Immunology, Immunotherapy : CII|March 30, 2024
23-Hydroxybetulinic acid attenuates 5-fluorouracil resistance of colorectal cancer by modulating M2 macrophage polarization via STAT6 signalingZeping Fan, Yaru Cui, Lanying Chen, et al.
Cancer Immunology, Immunotherapy : CII|March 30, 2024
PGRN inhibits CD8+T cell recruitment and promotes breast cancer progression by up-regulating ICAM-1 on TAMTing Zhou, Husun Qian, Dian Zhang, et al.
Cancer Immunology, Immunotherapy : CII|March 30, 2024
Targeting osteosarcoma with canine B7-H3 CAR T cells and impact of CXCR2 Co-expression on functional activityJennifer W Cao, Jessica Lake, Renata Impastato, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2024
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinomaKonstantinos S Papadakos, Gilar Gorji-Bahri, Chrysostomi Gialeli, et al.
Cancer Immunology, Immunotherapy : CII|October 2, 2024
Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world studyShanshan Wang, Jiashuo Chao, Hao Wang, et al.
Pageof 652